Citation Impact
Citing Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Diversity oriented clicking delivers β-substituted alkenyl sulfonyl fluorides as covalent human neutrophil elastase inhibitors
2022 StandoutNobel
Identification of the Tuberous Sclerosis Complex-2 Tumor Suppressor Gene Product Tuberin as a Target of the Phosphoinositide 3-Kinase/Akt Pathway
2002 Standout
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Increasing Global Mortality from Idiopathic Pulmonary Fibrosis in the Twenty-First Century
2014
Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand
2002 Standout
Idiopathic pulmonary fibrosis
2017 Standout
The Clinical Spectrum of Lymphatic Disease
2008
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
The Tuberous Sclerosis Complex
2006 Standout
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
2010 Standout
Decline in Lung Function in Patients With Lymphangioleiomyomatosis Treated With or Without Progesterone
2004
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
2004 StandoutNobel
Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis
2002
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
2020 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Tuberous sclerosis complex: Advances in diagnosis, genetics, and management
2007
IgE and mast cells in allergic disease
2012 Standout
Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer
2014
Nonresolving Inflammation
2010 Standout
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Putting tumours in context
2001 Standout
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Discoidin domain receptor tyrosine kinases: new players in cancer progression
2012
Upstream and downstream of mTOR
2004 Standout
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
2003 Standout
Tuberculosis and lung damage: from epidemiology to pathophysiology
2018 StandoutNobel
Fibrotic disease and the TH1/TH2 paradigm
2004 Standout
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
2003 StandoutNobel
Phosphorylation and Functional Inactivation of TSC2 by Erk
2005 Standout
Autophagy in the Pathogenesis of Disease
2008 Standout
Lymphangioleiomyomatosis — a wolf in sheep’s clothing
2012
Matrix metalloproteinases: effectors of development and normal physiology
2000
Remodelling the extracellular matrix in development and disease
2014 Standout
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
2002 Standout
Role of Proteases in Chronic Obstructive Pulmonary Disease
2017
Tuberous sclerosis
2008 Standout
mTOR treatment in lymphangioleiomyomatosis: the role of everolimus
2016
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Tumour suppressors hamartin and tuberin: intracellular signalling
2003
The Neurology of mTOR
2014
Protective effects of matrix metalloproteinase-12 following corneal injury
2013
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
2020 Standout
Alternative Activation of Macrophages: Mechanism and Functions
2010 Standout
International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update—A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation
2006
Remodeling in Asthma
2009
Airway Mucus Function and Dysfunction
2010 Standout
High Frequency of Pulmonary Lymphangioleiomyomatosis in Women With Tuberous Sclerosis Complex
2000
Defining the Role of mTOR in Cancer
2007 Standout
Association between Antibiotic Resistance and Community Prescribing: A Critical Review of Bias and Confounding in Published Studies
2001
AKT/PKB Signaling: Navigating the Network
2017 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
The PI3K Pathway in Human Disease
2017 Standout
A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells
2002
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
2020 Standout
Pulmonary Artery Pressure in Lymphangioleiomyomatosis
2007
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
2015
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
2013
Fibrotic Response of Tissue Remodeling in COPD
2011
Cellular senescence: from physiology to pathology
2014 Standout
Host–Microbial Interactions in Idiopathic Pulmonary Fibrosis
2017
Pulmonary Lymphangioleiomyomatosis in a Man
2000
Modulation of Cell Migration and Invasiveness by Tumor Suppressor TSC2 in Lymphangioleiomyomatosis
2005
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
The NHLBI Lymphangioleiomyomatosis Registry
2005
Mutational and Radiographic Analysis of Pulmonary Disease Consistent with Lymphangioleiomyomatosis and Micronodular Pneumocyte Hyperplasia in Women with Tuberous Sclerosis
2001
The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
2004 Standout
Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis
2019 StandoutNobel
Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches
2016
Tuberous sclerosis
2006
Rapamycin and Alzheimer’s disease: Time for a clinical trial?
2019
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis
2019 StandoutNobel
The Tuberous Sclerosis Complex and its Highly Variable Manifestations
2003
Aplastic Anemia
1982 StandoutNobel
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung
2000
Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism
2016
Human Airway Smooth Muscle Cells Express the High Affinity Receptor for IgE (FcεRI): A Critical Role of FcεRI in Human Airway Smooth Muscle Cell Function
2005
Lymphangioleiomyomatosis
2006
Dysregulation of the TSC-mTOR pathway in human disease
2004 Standout
Idiopathic Pulmonary Fibrosis
2018 Standout
Rejection of marrow from DLA-identical canine littermates given transfusions before grafting: antigens involved are expressed on leukocytes and skin epithelial cells but not on platelets and red blood cells
1979
Works of Simon R. Johnson being referenced
Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial
2011
Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis
2011
Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin
2001
Association of MMP - 12 polymorphisms with severe and very severe COPD: A case control study of MMPs - 1, 9 and 12in a European population
2010
Survival and disease progression in UK patients with lymphangioleiomyomatosis
2004
A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis
2013
Synthetic functions of airway smooth muscle in asthma
1997
The TSC‐2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma
2002
Clinical features of patients with -lactamase producing Haemophilus influenzae isolated from sputum
1996
Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study
2017
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis
2009
Secretory leukocyte protease inhibitor gene deletion alters bleomycin-induced lung injury, but not development of pulmonary fibrosis
2016
Levels of circulating MMP-7 degraded elastin are elevated in pulmonary disorders
2015
MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD
2008
Discoidin domain receptor 1 regulates bronchial epithelial repair and matrix metalloproteinase production
2010
The ERS guidelines for LAM: Trying a rationale approach to a rare disease
2010
Lymphangioleiomyomatosis
2006
Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case–control study
2013
Lymphangioleiomyomatosis
2002
Rare diseases bullet 1: Lymphangioleiomyomatosis: clinical features, management and basic mechanisms
1999
Matrix metalloproteinase-12 (MMP-12) SNP affects MMP activity, lung macrophage infiltration and protects against emphysema in COPD
2011
Clinical experience of lymphangioleiomyomatosis in the UK
2000
Matrix metalloproteinase expression and activity in human airway smooth muscle cells
2004
Decline in Lung Function in Lymphangioleiomyomatosis
1999
Autocrine production of matrix metalloproteinase-2 is required for human airway smooth muscle proliferation
1999
ONE-WAY NONSTIMULATION OF MIXED LEUKOCYTE CULTURE IN DOG FAMILIES
1975